LivaNova (LIVN) FCF Payout Ratio (2016 - 2017)
LivaNova (LIVN) reported FCF Payout Ratio of 0.21 for Q1 2017, down 89.3% on a YoY basis from 1.95 in Q1 2016, and up 2108.62% sequentially from 0.01 in Q4 2016.
LivaNova (LIVN) FCF Payout Ratio (2016 - 2017) Analysis & Trends
LivaNova (LIVN) has 2 years of FCF Payout Ratio data on file, last reported at 0.21 in Q1 2017.
- For the quarter ending Q1 2017, FCF Payout Ratio fell 89.3% year-over-year to 0.21; the trailing twelve-month figure through Mar 2017 stood at 0.13 (changed N/A YoY), and the FY2016 full-year result was 0.12, changed N/A from the prior year.
- FCF Payout Ratio climbed to 0.21 in Q1 2017, from 0.01 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 1.95 in Q1 2016 to a low of 0.01 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.20 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.81 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.44 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.14 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 0.21 |
| Dec 31, 2016 | -0.01 |
| Sep 30, 2016 | 0.12 |
| Mar 31, 2016 | 1.95 |